tradingkey.logo

IDEAYA Biosciences Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors

ReutersMay 6, 2025 10:51 AM

- IDEAYA Biosciences Inc IDYA.O:

  • IDEAYA BIOSCIENCES ANNOUNCES US FDA IND-CLEARANCE FOR IDE849, A POTENTIAL FIRST-IN-CLASS DLL3 TOP1 ADC, FOR A PHASE 1 STUDY IN SOLID TUMORS

  • IDEAYA BIOSCIENCES INC - TO START PHASE 1 STUDY IN U.S. BASED ON FDA GUIDANCE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI